Ghassemieh Bijan J, Attia Engi F, Koelle David M, Mancuso James D, Narita Masahiro, Horne David J
1 Division of Pulmonary and Critical Care Medicine, Department of Medicine.
2 Division of Allergy and Infectious Diseases, Department of Medicine.
Am J Respir Crit Care Med. 2016 Aug 15;194(4):493-500. doi: 10.1164/rccm.201508-1560OC.
Latent tuberculosis infection (LTBI) test discordance is poorly understood.
To determine the frequency and predictors of tuberculin skin test (TST) and QuantiFERON-TB Gold In-Tube test (QFT) discordance in the U.S.
We analyzed data from a representative sample of the U.S. population ages 6 years and older who participated in the 2011-2012 National Health and Nutrition Examination Survey. We determined prevalence estimates of test positivity, calculated test agreement and kappa statistics, and performed multivariable logistic regression to determine predictors of discordance.
LTBI prevalence among the U.S. born ranged from 0.6% to 2.8%, depending on how LTBI was defined, with test agreement 97.0% and kappa 0.27 (95% confidence interval, 0.18-0.36). Prevalence among the foreign born ranged from 9.1% to 20.3%, depending on how LTBI was defined, with test agreement 81.6% and kappa 0.38 (95% confidence interval, 0.33-0.44). TST(+)/QFT(-) discordance was associated with age, male sex, black race, Mexican-American ethnicity, previous TB exposure, and past LTBI treatment in U.S.-born participants, but only with higher lymphocyte count in foreign-born participants. TST(-)/QFT(+) discordance was associated with older age, previous TB exposure, and past LTBI treatment in U.S.-born participants and with older age, male sex, and past LTBI treatment in foreign-born participants.
In the largest population-based sample of concurrently performed TST and QFT tests in a low tuberculosis incidence population, prevalence estimates depended heavily on how LTBI was defined and test agreement was only fair. We identified several predictors of discordance warranting further study.
潜伏性结核感染(LTBI)检测结果不一致的情况尚未得到充分理解。
确定美国结核菌素皮肤试验(TST)和全血γ干扰素释放试验(QFT)结果不一致的频率及预测因素。
我们分析了参加2011 - 2012年美国国家健康与营养检查调查的6岁及以上美国代表性人群样本的数据。我们确定了检测阳性率的估计值,计算了检测一致性和kappa统计量,并进行多变量逻辑回归以确定不一致的预测因素。
在美国出生人群中,LTBI患病率在0.6%至2.8%之间,具体取决于LTBI的定义方式,检测一致性为97.0%,kappa值为0.27(95%置信区间,0.18 - 0.36)。在外国出生人群中,患病率在9.1%至20.3%之间,具体取决于LTBI的定义方式,检测一致性为81.6%,kappa值为0.38(95%置信区间,0.33 - 0.44)。在美国出生的参与者中,TST(+)/QFT(-)不一致与年龄、男性、黑人种族、墨西哥裔美国人种族、既往结核暴露以及既往LTBI治疗有关,但在外国出生的参与者中仅与淋巴细胞计数较高有关。在美国出生的参与者中,TST(-)/QFT(+)不一致与年龄较大、既往结核暴露以及既往LTBI治疗有关,在外国出生的参与者中与年龄较大、男性以及既往LTBI治疗有关。
在低结核病发病率人群中同时进行TST和QFT检测的最大规模基于人群的样本中,患病率估计值很大程度上取决于LTBI的定义方式,检测一致性仅为一般。我们确定了几个不一致的预测因素,值得进一步研究。